Avita Drugs Sold to Long’s Drugs

We represented Avita Drugs Inc. in its sale to Long’s Drugs Inc., a portfolio company of Tailwind Capital.

Avita is a leading specialty pharmacy serving chronically ill patient populations in Louisiana, Texas, North Carolina, South Carolina and Virginia.

Long’s is a comprehensive pharmacy services provider in South Carolina, North Carolina and Georgia.

Tailwind Capital is a leading middle market private equity firm focused on growth-oriented investments in targeted sectors within healthcare, business and industrial services.

You Also May Be Interested In:

  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company
  • We represented Verdi Oncology, Inc. in its acquisition of NexGen Oncology. With the acquisition of NexGen, Verdi has launched Verdi...
    Client Type: Private Company
  • Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee

    We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its...
    Client Type: Private Company